To determine the mechanism of differential responses to anti-PD-1 therapy, single-cell whole transcriptome profiling for tumor xenografts from control IgG2a (n = 2), responders (n = 2), and non-responders (n = 2) were performed. Here, PDCD1 is linked to neoplasm.